drugset / Trial / NCT02289430

to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

NCT02289430

Phase 1 Completed 59 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the drug interaction of pharmacokinetics of rosuvastatin and ezetimibe.

Timeline

Start
2014-12
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown
Comparator Rosuvastatin Small molecule

Indications

No indication recorded.